A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression

文献情報

出版日 2023-02-22
DOI 10.1039/D2CP05676C
インパクトファクター 3.676
著者

Panpan Wang, Fengmei Yan, Jianghong Dong, Shengqiang Wang, Yu Shi, Mengdan Zhu, Yuting Zuo, Hui Ma, Ruirui Xue, Dingjie Zhai, Xiaoyu Song


原文を見る

要旨

Depression severely impairs the health of people all over the world. Cognitive dysfunction due to depression has resulted in a severe economic burden to family and society induced by the reduction of social functioning of patients. Norepinephrine-dopamine reuptake inhibitors (NDRIs) targeted with the human norepinephrine transporter (hNET) and distributed with the human dopamine transporter (hDAT) simultaneously treat depression and improve cognitive function, and they effectively prevent sexual dysfunction and other side effects. Because many patients continue to poorly respond to NDRIs, it is urgent to discover novel NDRI antidepressants that do not interfere with cognitive function. The aim of this work was to selectively identify novel NDRI candidates acting against hNET and hDAT from large compound libraries by a comprehensive strategy integrating support vector machine (SVM) models, ADMET, molecular docking, in vitro binding assays, molecular dynamics simulation, and binding energy calculation. First, 6522 compounds that do not inhibit the human serotonin transporter (hSERT) were obtained by SVM models of hNET, hDAT, and non-target hSERT with similarity analyses from compound libraries. ADMET and molecular docking were then used to identify compounds that could potently bind to the hNET and hDAT with satisfactory ADMET, and 4 compounds were successfully identified. According to their docking scores and ADMET information, 3719810 was advanced for profiling by in vitro assays as a novel NDRI lead compound due to its strongest druggability and balancing activities. Encouragingly, 3719810 performed comparative activities on two targets, with Ki values of 7.32 μM for hNET and 5.23 μM for hDAT. To obtain candidates with additional activities and balance the activities of 2 targets, 5 analogs were optimized, and 2 novel scaffold compounds were successively designed. By assessment of molecular docking, molecular dynamics simulations, and binding energy calculations, 5 compounds were validated as NDRI candidates with high activities, and 4 of them performed acceptable balancing activities acting on hNET and hDAT. This work supplied promising novel NDRIs for treatment of depression with cognitive dysfunction or other related neurodegenerative disorders, and also provided a strategy for highly efficient and cost-effective identification of inhibitors for dual targets with homologous non-targets.

関連文献

Effects of the c-Si/a-SiO2 interfacial atomic structure on its band alignment: an ab initio study

Fan Zheng, Hieu H. Pham, Lin-Wang Wang

2017-11-13 Paper

DOI: 10.1039/C7CP05879A

How the hydrogen sorption properties of palladium are modified through interaction with iridium

Christine Goyhenex, Laurent Piccolo

2017-11-22 Paper

DOI: 10.1039/C7CP07155H

Nitrate-assisted photocatalytic efficiency of defective Eu-doped Pr(OH)3 nanostructures

S. Aškrabić, V. D. Araújo, M. Passacantando, M. I. B. Bernardi, N. Tomić, B. Dojčinović, D. Manojlović, B. Čalija, M. Miletić, Z. D. Dohčević-Mitrović

2017-11-07 Paper

DOI: 10.1039/C7CP06440C

Detection of a weak ring current in a nonaromatic porphyrin nanoring using magnetic circular dichroism

Patrycja Kowalska, Martin D. Peeks, Tomasz Roliński, Harry L. Anderson

2017-11-22 Paper

DOI: 10.1039/C7CP07348H

Front cover

Cover

DOI: 10.1039/C7CP90271A

B12Fn0/− (n = 1–6) series: when do boron double chain nanoribbons become global minima?

Hui Bai, Bing Bai, Lin Zhang, Wei Huang, Hua-Jin Zhai, Si-Dian Li

2017-11-07 Paper

DOI: 10.1039/C7CP05658C

The structure and catalytic properties of Rh-doped CeO2 catalysts

V. A. Svetlichnyi, A. S. Ivanova

2017-11-09 Paper

DOI: 10.1039/C7CP06573F

Dynamics of poly(vinyl butyral) studied using dielectric spectroscopy and 1H NMR relaxometry

Silvia Pizzanelli, Daniele Prevosto, Massimiliano Labardi, Tommaso Guazzini, Simona Bronco, Claudia Forte, Lucia Calucci

2017-11-13 Paper

DOI: 10.1039/C7CP02595E

On the underlying mechanisms of the low observed nitrate selectivity in photocatalytic NOx abatement and the importance of the oxygen reduction reaction

Julia Patzsch, Andrea Folli, Donald E. Macphee, Jonathan Z. Bloh

2017-11-27 Paper

DOI: 10.1039/C7CP05960D

こちらもおすすめ

化合物よくある質問

S-(甲硅烷基丙基)異硫酰氯を取り扱う際の実験室安全事項は何ですか?

取り扱う際にはPPE(防護具)が必要です。特に手袋と面マスクは必須です。ドラフトチャンバーを使用して漏洩処理を行い、温度は常温、湿度は乾燥状態、容器はガラス容器...

84682-36-02-Amino-7,7-dimethox...
化合物よくある質問

8-硝基-咪唑并[1,2-a]吡啶とは何ですか?

8-硝基-咪唑并[1,2-a]吡啶は、CAS番号52310-46-0の化合物で、8-位に硝基を有する咪唑並みの结构をもつ吡啶の化合物です。この化合物は、酸化還元...

52310-46-08-Nitroimidazo[1,2-a...
化合物よくある質問

4-ブロモ-5-メトキシピリジン-2-甲醇の代替品はありますか?

4-ブロモ-5-メトキシピリジン-2-甲醇の代替品には、類似構造を持つ化合物や機能性に等しい代替試薬があります。例えば、4-クロロ-5-メトキシピリジン-2-甲...

1454849-84-3(4-Bromo-5-methoxy-2...
化合物よくある質問

全氟-1,2-二甲基環己烷を含む廃棄物はどのように処理すべきですか?

全氟-1,2-二甲基環己烷(CAS番号:306-98-9)の廃棄物は、特別な処理が必要です。まず、廃棄物を密閉容器に収集し、適切な防漏容器に保管します。次に、専...

306-98-91,1,2,2,3,3,4,4,5,6-...
化合物よくある質問

3-(溴甲基)苯乙酸の主な用途は何ですか?

3-(溴甲基)苯乙酸は主に研究用化学薬品として利用され、有機合成や医薬品の開発に用いられます。また、特定の化合物の合成中間体としても使用されることがあります。

118647-53-32-(3-(Bromomethyl)ph...
化合物よくある質問

5-イドキド-4-メチオキシ-6-メチルピリミジニン-2-アミンはどのように保存すればよいですか?

5-イドキド-4-メチオキシ-6-メチルピリミジニン-2-アミンは冷暗所で密栓の容器に保存し、直射日光を避けて保管することをお勧めします。温度は常温とし、湿気を...

23368-84-55-Iodo-4-methoxy-6-m...
化合物よくある質問

1-(2-溴-6-甲氧基苯基)乙酮を取り扱う際の実験室安全事項は何ですか?

実験室では、1-(2- Bromo-6-methoxyphenyl)ethanoneを取り扱う際には、ゴーグルや面具、手袋などのPPEを使用することが推奨されま...

380225-68-31-(2-Bromo-6-methoxy...
化合物よくある質問

5-(4,4,5,5-テトラメチル-1,3,2-ダイオキサボラロール-2-イル)-1,3-ジヒドロ-2-ベンゾフランは安全ですか?

5-(4,4,5,5-テトラメチル-1,3,2-ダイオキサボラロール-2-イル)-1,3-ジヒドロ-2-ベンゾフランは一般に安全ですが、取扱いには注意が必要です...

1352037-60-55-(4,4,5,5-Tetrameth...
化合物よくある質問

4-溴萘-1-甲酸の代替品はありますか?

4-溴萘-1-甲酸は比較的稀な化合物ですが、類似物としては、4-クロロ-1-ナフホリック酸やその他のブロモ置換ナフホリック酸が挙げられます。ただし、これらの代替...

16650-55-84-Bromo-1-naphthoic ...
化合物よくある質問

ε-白藜芦醇脱氢二聚体の代替品はありますか?

ε-白藜芦醇脱氢二聚体の代替品としては、ε-白藜芦醇、ポリフェノール類、フラボノイド類が挙げられます。これらは類似の化学構造と生物学的活性を持っています。ただし...

62218-08-05-{(2R,3R)-6-Hydroxy...

掲載誌

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
自己引用率: 10.3%
年間論文数: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

おすすめ化合物

おすすめサプライヤー

免責事項
このページに表示される学術雑誌情報は、参考および研究目的のみを目的としています。当社は雑誌出版社とは提携しておらず、投稿の取り扱いも行っておりません。出版に関するお問い合わせは、各雑誌出版社に直接ご連絡ください。
表示されている情報に誤りがある場合は、support@chemtradehub.com までご連絡ください。迅速に確認し、対応いたします。